Phase II study of sequential gemcitabine followed by docetaxel for recurrent ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: Results of sarcoma alliance for research through Collaboration study 003

Oncologist

Volumn 17, Issue 3, 2012, Pages 321-

  Fox, Elizabeth ^a,f   Patel, Shreyaskumar ^b   Wathen, J Kyle ^b   Schuetze, Scott ^c   Chawla, Sant ^d   Harmon, David ^e   Reinke, Denise ^c   Chugh, Rashmi ^c   Benjamin, Robert S ^b   Helman, Lee j ^f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Sarcoma Oncology Center   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GEMCITABINE;

ANEMIA; ARTICLE; BACKACHE; BAYES THEOREM; BRONCHOSPASM; CELLULITIS; CHONDROSARCOMA; DEATH; DISEASE COURSE; DYSPNEA; EDEMA; EWING SARCOMA; FATIGUE; HEART TAMPONADE; HEMOPTYSIS; HUMAN; INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MYOSITIS; NEUROPATHY; NEUTROPENIA; OSTEOSARCOMA; PERICARDIAL EFFUSION; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHONDROSARCOMA; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; SARCOMA, EWING; TAXOIDS;

EID: 84859381932     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0265     Document Type: Article

References (0)